LVAD as destination therapy - The economic dilemma

IEEE Technology and Society Magazine

Volumn 23, Issue 2, 2004, Pages 23-27

  Douglas, Pamela ^a   Morgan, Courtney ^a   Lee, Heather ^a   Foster, Kenneth R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; COSTS; HEALTH CARE; HEALTH INSURANCE; IMPLANTS (SURGICAL); PUBLIC POLICY; TRANSPLANTATION (SURGICAL); TRANSPLANTS;

END STAGE HEART FAILURE; HEART TRANSPLANT; LEFT VENTRICULAR ASSIST DEVICE; UNSUSTAINABLE MEDICAL COSTS;

ARTIFICIAL ORGANS;

EID: 3342948694     PISSN: 02780097     EISSN: None     Source Type: Journal    
DOI: 10.1109/MTAS.2004.1304397     Document Type: Article

References (8)

1. W. B. Kannel et al., "Changing epidemiological features of cardiac failure," Br. Heart J., vol. 72, Suppl. 2, pp. S3-9, 1994.
2. E. A. Rose et al., "Long-term mechanical left ventricular assistance for end-stage heart failure," N. Engl. J. Med., vol. 345, no. 20, pp. 1435-1443, 2001.
3. R. Hetzer, J. H. Müller, Y-G Weng, R. Meyer, and M. Dandel, "Bridging-to-recovery," Ann. Thorac. Surg., vol. 71, Suppl. 1, p. S109-S113, 2001.
4. A.J. Moskowitz, E.A. Rose, and A.C. Gelijns, "The cost of long-term LVAD implantation," Ann. Thorac. Surg., vol. 71, Suppl. 3, pp. S195-8, 2001.
5. W. Morgan, "Securities analysis of Thoratec," Rep., Jan. 15, 2002. Available on the Internet at einvestmentbank.com/research/011502thor.pdf
6. D. Callahan, "Too much of a good thing: How splendid technologies can go wrong," Hastings Center Rep., vol. 33, no. 2, pp. 19-22, 2003.
7. D.J. Rothman, Beginnings Count. New York, NY: Oxford Univ. Press 1997.
8. K. Davis and C. Schoen, "Creating consensus on coverage choices," The Commonwealth Fund, New York, NY, 2003. Available on the Internet at http://www.healthaffairs.org/WebExclusives/2203Davis.pdf